Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger
Promino expands its U.S. NCAA NIL platform with Every True Tiger, the third-party marketing arm of the Missouri Tigers, and...
Day: June 18, 2026
Frontier Specialty Chemicals Sees Increased Website Engagement Following Bioz Badge Addition
PALO ALTO, CA / ACCESS Newswire / June 18, 2026 / Bioz, Inc., a globally trusted platform for structuring actionable...
New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF
Not intended for UK and US audiences Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European...
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement
REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the...
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company...
BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum
2026 marks BIO-Europe's evolution from partnering-led conference into the continent's largest biopharma strategy forumExpands its program to convene the full...
Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470
Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China,...
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
Filing acceptance based on data from the phase III SUNMO study where subcutaneous Lunsumio VELO plus Polivy demonstrated a 59%...
F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis
The study achieved the primary endpoint of non-inferiority, with a rate of all-cause mortality (ACM) at Day 42 for olorofim...
Legend Biotech Corporation Announces Pricing of Public Offering
BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global...
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or...
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
Acquisition adds multiple immunology assets to Biogen’s portfolio, including a lead asset poised to enter Phase 1 developmentCAMBRIDGE, Mass. and...
Zelluna ASA – Mandatory notification of trade – Subscription and share lending in Private Placement
Oslo, 18 June 2027: Reference is made to the stock exchange announcement published by Zelluna ASA (the "Company") on 17...
Zelluna ASA: Private Placement and Retail Offering successfully placed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG...
Premier Health of America Provides Update on Management Cease Trade Order
MONTREAL, June 17, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”, or the “Company”) is...
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology...
Certara Announces CFO Transition
Reaffirms 2026 GuidanceRADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug...
Postponement and Re-scheduling of Annual General Meeting
June 17, 2026 Biodexa Pharmaceuticals PLC Postponement and Re-scheduling of Annual General Meeting Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or...
New Potential Energy-Rockefeller Foundation Study: Climate Support Strong Across Leading Democracies, But Words Matter
On the heels of the G7 Summit, a study of more than 83,000 adults across six of the seven countries...
June 29th DEA Hearing: The Marijuana Industry That Stole the Word “Medical” Is Now Choking on It
"State licensed cannabis programs stole the language of medicine without ever submitting to FDA drug development standards that make a...